Cyclic Pamidronate Infusion for Neonatal-onset Osteogenesis Imperfecta

Cyclic Pamidronate Infusion for Neonatal-onset Osteogenesis Imperfecta

Patients with severe osteogenesis imperfecta (OI; MIM number 259420) suffer from low bone mass, fractures, and bone pain since birth, and have poor prognosis. This study assessed the outcome of patients with severe OI who were treated with cyclic pamidronate prior to the age of 1 year. Methods: The...

Full description

Saved in:
Bibliographic Details
Main Authors: Chia-Hsuan Lin, Yin-Hsiu Chien, Shinn-Forng Peng, Wen-Yu Tsai, Yi-Ching Tung, Cheng-Ting Lee, Chun-Ching Chien, Wuh-Liang Hwu, Ni-Chung Lee
Format: Article
Language:English
Published: Elsevier 2014-08-01
Series:Pediatrics and Neonatology
Subjects:
bisphosphonate
bone mineral density
neonate
osteogenesis imperfecta
Online Access:http://www.sciencedirect.com/science/article/pii/S1875957213002337
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S1875957213002337

Similar Items